Page 31 - 2023-02-中国全科医学

·152· http: //www.chinagp.net E-mail: zgqkyx@chinagp.net.cn January 2023, Vol.26 No.2

［8］SHEA B J，REEVES B C，WELLS G，et al. AMSTAR 2：a critical disease［J］. Coron Artery Dis，2019，30（6）：393-397.
appraisal tool for systematic reviews that include randomised or non- DOI：10.1097/MCA.0000000000000740.
randomised studies of healthcare interventions，or both［J］. BMJ， ［18］WANG L J，HAN S，ZHANG X H，et al. Fractional flow
2017，358：j4008. DOI：10.1136/bmj.j4008. reserve-guided complete revascularization versus culprit-only
［9］BALSHEM H，HELFAND M，SCHÜNEMANN H J，et al. revascularization in acute ST-segment elevation myocardial
GRADE guidelines：3. Rating the quality of evidence［J］. J infarction and multi-vessel disease patients：a meta-analysis and
Clin Epidemiol，2011，64（4）：401-406. DOI：10.1016/j. systematic review［J］. BMC Cardiovasc Disord，2019，19（1）：
jclinepi.2010.07.015. 49. DOI：10.1186/s12872-019-1022-6.
［10］SPENCER F A，SEKERCIOGLU N，PRASAD M，et al. Culprit ［19］PANDIT A，ARYAL M R，ARYAL PANDIT A，et al. Preventive
vessel versus immediate complete revascularization in patients PCI versus culprit lesion stenting during primary PCI in acute
with ST-segment myocardial infarction-a systematic review［J］. STEMI：a systematic review and meta-analysis［J］. Open Heart，
Am Heart J，2015，170（6）：1133-1139. DOI：10.1016/j. 2014，1（1）：e000012. DOI：10.1136/openhrt-2013-000012.
ahj.2015.09.002. ［20］CHATTERJEE S，KUNDU A，MUKHERJEE D，et al. Risk of
［11］PASCERI V，PATTI G，PELLICCIA F，et al. Complete contrast-induced acute kidney injury in ST-elevation myocardial
revascularization during primary percutaneous coronary intervention infarction patients undergoing multi-vessel intervention-meta-
reduces death and myocardial infarction in patients with multivessel analysis of randomized trials and risk prediction modeling study
disease：meta-analysis and meta-regression of randomized using observational data［J］. Catheter Cardiovasc Interv，2017，
trials［J］. JACC Cardiovasc Interv，2018，11（9）：833-843. 90（2）：205-212. DOI：10.1002/ccd.26928.
DOI：10.1016/j.jcin.2018.02.028. ［21］BANGALORE S，TOKLU B，WETTERSLEV J. Complete versus
［12］ELGENDY I Y，WEN X R，MAHMOUD A，et al. Complete versus culprit-only revascularization for ST-segment-elevation myocardial
culprit-only revascularization for patients with multi-vessel disease infarction and multivessel disease：a meta-analysis and trial
undergoing primary percutaneous coronary intervention：an updated sequential analysis of randomized trials［J］. Circ Cardiovasc
meta-analysis of randomized trials［J］. Catheter Cardiovasc Interv，2015，8（4）：e002142. DOI：10.1161/CIRCINTERVE
Interv，2016，88（4）：501-505. DOI：10.1002/ccd.26322. NTIONS.114.002142.
［13］MUKETE B N，RIEHL R A，ALONSO A，et al. Multivessel ［22］BRAVO C A，HIRJI S A，BHATT D L，et al. Complete versus
revascularization does not increase contrast-induced acute culprit-only revascularisation in ST elevation myocardial infarction
kidney injury incidence in acute myocardial infarction：a meta- with multi-vessel disease［J］. Cochrane Database Syst Rev，
analysis［J］. Am J Cardiovasc Drugs，2016，16（6）：419- 2017，5（5）：CD011986. DOI：10.1002/14651858.CD011986.
426. DOI：10.1007/s40256-016-0184-1. pub2.
［14］WANG C H，ZHANG S Y，JIN X F. Complete revascularization ［23］AHMAD Y，HOWARD J P，ARNOLD A，et al. Complete
versus culprit-only revascularization in ST-segment elevation revascularization by percutaneous coronary intervention for patients
myocardial infarction and multivessel disease patients undergoing with ST-segment-elevation myocardial infarction and multivessel
primary percutaneous coronary intervention：a meta-analysis and coronary artery disease：an updated meta-analysis of randomized
trial sequential analysis［J］. Int J Cardiol，2017，228：844- trials［J］. J Am Heart Assoc，2020，9（12）：e015263. DOI：
852. DOI：10.1016/j.ijcard.2016.11.186. 10.1161/JAHA.119.015263.
［15］BAINEY K R，WELSH R C，TOKLU B，et al. Complete vs ［24］EL-HAYEK G E，GERSHLICK A H，HONG M K，et al. Meta-
culprit-only percutaneous coronary intervention in STEMI with analysis of randomized controlled trials comparing multivessel versus
multivessel disease：a meta-analysis and trial sequential analysis of culprit-only revascularization for patients with ST-segment elevation
randomized trials［J］. Can J Cardiol，2016，32（12）：1542- myocardial infarction and multivessel disease undergoing primary
1551. DOI：10.1016/j.cjca.2016.02.077. percutaneous coronary intervention［J］. Am J Cardiol，2015，
［16］AL-ABDOUH A，BARBARAWI M，BIZANTI A，et al. Complete 115（11）：1481-1486. DOI：10.1016/j.amjcard.2015.02.046.
revascularization in patients with STEMI and multi-vessel disease： ［25］FORTUNI F，CRIMI G，ANGELINI F，et al. Early complete
a meta-analysis of randomized controlled trials［J］. Cardiovasc revascularization in hemodynamically stable patients with
Revasc Med，2020，21（5）：684-691. DOI：10.1016/j. ST-segment elevation myocardial infarction and multivessel
carrev.2020.01.020. disease［J］. Can J Cardiol，2019，35（8）：1047-1057. DOI：
［17］NEUPANE S，SINGH H，EDLA S，et al. Meta-analysis of 10.1016/j.cjca.2019.03.006.
fractional flow reserve guided complete revascularization versus ［26］GUPTA A，BAJAJ N S，ARORA P，et al. FFR-guided multivessel
infarct related artery only revascularization in patients with ST- stenting reduces urgent revascularization compared with infarct-
elevation myocardial infarction and multivessel coronary artery related artery only stenting in ST-elevation myocardial infarction：